Sales Scenario of Medical Image Analysis Software Market to Remain Incremental Through 2022

29/lug/2020 08:10:08 persistencemarketresearch Contatta l'autore

Global demand for  animal drug compounding  is expected to significantly increase, owing to the unavailability of FDA-approved animal drugs. Compounded prescriptions for animal species are considered to be significantly higher than those for branded prescription drugs.

For instance, in 2017, the US FDA estimated that,  75,000  pharmacies in the US fill  6,350,000  animal compounding prescriptions.

Get Sample Copy of Report @ https://www.persistencemarketresearch.com/samples/12871 

Company Profiles 

  • Hoye's Pharmacy
  • Vertisis Custom Pharmacy
  • Smith Caldwell Drug Store
  • Sixth Avenue Medical Pharmacy
  • Dougherty's Pharmacy
  • Triangle Compounding Pharmacy Inc.
  • Medisca Inc.
  • Wedgewood Pharmacy
  • Millers Pharmacy
  • Chiron Compounding Pharmacy
  • MEDS Canadian Compounding Pharmacy
  • Aurora Compounding
  • Pace Pharmacy
  • Victoria Compounding Pharmacy
  • Pratt’s Compounding Pharmacy
  • People’s Choice Pharmacy

Get To Know Methodology of Report @ https://www.persistencemarketresearch.com/methodology/12871

Persistence Market Research predicts that, the global animal drug compounding market would be valued at US$ 1.5 Bn in 2019, and will expand at an 8% CAGR over the forecast period (2019-2029).

Key Takeaways of Animal Drug Compounding Market Study

Hormonal drugs, manipulating the emotions and moods of pets, are expected to gain traction during the forecast period.

Increasing adoption of companion animals is expected to contribute to significant dominance of the segment during the forecast period.

Orally formulation of drugs is expected to hold more than  80%  of the global animal drug compounding market share by the end of 2029.

In terms of formulation, the injectable segment is expected to grow  1.6X  by the end of 2029.

Access Full Report @ https://www.persistencemarketresearch.com/checkout/12871 

Leading medical & pharmaceutical companies are collaborating with small compounding solution providers, hospitals, and research facilities to strengthen their market position.

North America is expected to dominate the global animal drug compounding market, owing to increasing adoption of compounded medication with alternate dosage forms and added flavors.

"Unavailability of generic medications for animals in desired dosage forms is pushing the production of compounded drugs, thus driving the growth of the animal drug compounding market during the forecast period,"  says a PMR analyst.

CNS Drugs Dominating Animal Drug Compounding Market

Central nervous system inflammation is the most common cause of neurological disorders in dogs and cats. Abnormal limb coordination, seizures, behavioral changes, and blindness are cited as the most common abnormalities in dogs and cats with central nervous system inflammation.

For instance, according to the International Journal of Pharmaceutical Compounding, central nervous system drugs were the most commonly dispensed medications from animal drug compounding pharmacies with approximately  39%  of the total veterinary prescriptions.

What Does the Report Cover?

Persistence Market Research offers a unique perspective and actionable insights on the animal drug compounding market in its latest study, presenting historical demand assessment from 2014-2018 and projections from 2019-2029, on the basis of product type (CNS agents, anti-infective agents , hormones and substitutes, anti-inflammatory agents, others), animal type (companion animals and livestock), formulation (oral, injectable, and others), across seven key regions.

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl